Catalyst Wire Dossier Catalyst Wire Dossier

Abraxane plus carboplatin

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Abraxane plus carboplatin, covering 2018-12-07 to 2018-12-07. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer [Phase 3]

See pricing